The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report
Business Wire India Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China,…
The 6 Smart Headphones for Audiophiles
Are you an audiophile looking for the best smart headphones on the market? Look no further! We’ve compiled a list…
The Offshore Crypto Problem Regulators Can No Longer Ignore
New Delhi, Apr 01 : Globally, the virtual digital asset (VDA) space is emerging as one of the fastest-growing and…